Bartosz Małkiewicz
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (11)
Background. Lymphovascular invasion (LVI) is a vital but often overlooked prognostic factor in prostate cancer. As debates on lymphadenectomy’s overtreatment emerge, understanding LVI laterality gains importance. This study pioneers the investigation into PCa, aiming to uncover patterns that could influence tailored surgical strategies in the future. Methods. Data from 96 patients with both LVI and lymph node invasion (LNI) were retrospectively analyzed. All participants underwent radical prostatectomy (RP) with modified-extended pelvic lymph node dissection (mePLND). All specimens underwent histopathological examination. The assessment of LVI was conducted separately for the right and left lobes of the prostate. Associations within subgroups were assessed using U-Mann–Whitney and Kruskal–Wallis tests, as well as Kendall’s tau-b coefficient, yielding p-values and odds ratios (ORs). Results. Out of the 96 patients, 61 (63.5%) exhibited exclusive left-sided lymphovascular invasion (LVI), 24 (25.0%) had exclusive right-sided LVI, and 11 (11.5%) showed bilateral LVI. Regarding nodal involvement, 23 patients (24.0%) had LNI solely on the left, 25 (26.0%) exclusively on the right, and 48 (50.0%) on both sides. A significant correlation was observed between lateralized LVI and lateralized LNI (p < 0.001), particularly in patients with right-sided LVI only. LN-positive patients with left-sided LVI tended to have higher pT stages (p = 0.047) and increased odds ratios (OR) of bilateral LNI (OR = 2.795; 95% confidence interval [CI]: 1.231–6.348) compared to those with exclusive right-sided LVI (OR = 0.692; 95% CI: 0.525–0.913). Conclusions. Unilateral LVI correlates with ipsilateral LNI in PCa patients with positive LNs, notably in cases of exclusively right-sided LVI. Left-sided LVI associates with higher pT stages and a higher percentage of bilateral LNI cases.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (17)
Wojciech Krajewski
Wroclaw Medical University
Tomasz Szydełko
Wroclaw Medical University
Artur Lemiński
Pomeranian Medical University
Marcin Słojewski
Head of Dept. Prof. of Urology
Pomeranian Medical University
Mateusz Czajkowski
Medical University of Gdansk
Anna Tomkiewicz
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy
Anna Kotulak-Chrząszcz
Medical University of Gdansk
Piotr Wierzbicki
Adjunct/Assistant Professor
Medical University of Gdansk
Roman Sosnowski
Professor
Narodowy Instytut Onkologii im Marii Skłodowskiej-Curie Państwowy Instytut Badawczy w Warszawie
Marek Bolanowski
Prof
Medical University of Silesia
Agnieszka Siennicka
Head, Vice-Dean (Faculty of Health Sciences)
Wroclaw Medical University
Anna Andrzejczak
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy
Zbigniew Kmieć
Medical University of Gdansk
Aleksandra Pawlak
Wroclaw University of Environmental and Life Sciences
Przemysław Szuba
-
Kuba Ptaszkowski
Wroclaw Medical University
AGNIESZKA HAŁOŃ
Professor
Medical University of Silesia
Make your next move.
Prepare your application
Review drafts before you send them.